Epidemiological Investigation of New SARS-CoV-2 Variant of Concern 202012/01 in England

The impact of the new variant on the diagnostic testing

The proportion in England of positive specimens tested using the ThermoFisher TaqPath™ COVID-19 assay with failure of S-gene target detection increased rapidly in December 2020 rising to over 70% of strong positive test results detected within the facility at the beginning of January 2021 (Figure 1, five-day rolling rate). The failure of S-gene detection does not significantly alter the clinical validity of the test result as detection of the alternate target (ORF1Ab and N) has remained robust.

• Download figure
• Open in new tab

Figure 1. TaqPath™ COVID 19 Assay, S-gene detection in comparison to ORF1ab and N-gene.

Epidemiological clusters associated with S-gene target failure

Samples tested at Alderley Park Lighthouse Labs, from the 1^st to the 21^st of December 2020, were collected and linked to geographical area within England (Table 1; Figure 2; supporting information video map).

• Download figure
• Open in new tab

Figure 2. Map of S-gene detection failure,

associated with the new SARS-CoV-2 variant. Data collected at Alderley Park, Lighthouse Labs, from 1^st to 21^st of December 2020.

The distribution of S-gene target failure cases shows a relatively higher burden in London, East-South East, parts of the North West, South west regions and West Midlands. While the sample collection and distribution network load balancing does not allow that the same number of samples is delivered consistently from each geographic area the data does provide some indication on the national geographic spread of the variant with time. As sample numbers were not collected equally from each region a low detection rate cannot be considered conclusive proof of the variant not being present. However, when viewed as a percentage of samples the data clearly shows a geographical bias within the overall sample set. Clustering was observed around population centres of London, cities of the coastal South, Manchester, Birmingham, Bristol and Liverpool (Figure 2).

Areas with the highest incidence in our study also coincide with areas now reporting high levels of patient hospitalisation (NHS, 2021). The timeline view identifies the rapid spread of this in high population areas across the country and reinforces the necessity of subsequent National lockdown to contain spread of the variant.

Molecular analysis of Virus strains associated with S-gene target failure – Pending Work

Samples of extracted RNA tested at Alderley Park, Lighthouse Labs, were sequenced at the Wellcome Sanger Institute, Cambridge, UK.

At the beginning of December, the Sanger Institute has identified and sequenced a significant number of samples with negative S-gene target detection by the TaqPath™ COVID 19 Kit, but positive for the ORF1ab and N-gene targets. Analysis showed that Spike protein mutations characteristic of VOC 202012/01 were present in these S-gene target detection failure cases indicating the predictive nature of our S-gene target detection failure for the presence of the VOC. However, ongoing molecular surveillance is needed to ensure identify mutations, which are currently preventing amplification of the S-gene target, remain characteristic of the VOC.

Sample acquisition

Samples delivered to the LH laboratory, Alderley Park, can be derived from any area of the UK. A distribution network load balances sample distribution to one of the five major UK centres daily. Sample tracking data is held centrally in a proprietary data base (Edge; Department of Health and Social Care, UK).

SARS-CoV-2 Testing

Nose and throat swab samples in virus transport medium collected at a variety of test centres and home self-collected samples shipped to Alderley Park were extracted using the MagMAX™ Viral/Path-ogen Nucleic Acid Isolation Kit (Thermofisher, Warrington, UK) and Kingfisher Flex extraction platform (ThermoFisher). PCR amplification used the TaqPath™ COVID-19 Combo Kit (Thermofisher) and 384 well format on Quantstudio Flex 7 System and UgenTec-FastFinder PCR analysis software (Eugentec, Hasselt, Belgium). S-gene target detection failure was defined where: ORF1ab Cq value lower than 31.6; N-gene Cq lower than 30.1; S-gene target was not amplified. Those cases were linked to the new SARS-CoV-2 variant.

Geographical origins of samples

Subject postal district, (Figure 2 and supporting information video map), and test region (Table 1), were extracted via interrogation of the Edge data.

Data analysis

Figure 1. December data available in Table 3 (last column) showing daily figures and five-day rolling rate of S-gene Target Failure per total number of strong positive test results. The same method was used for the five-day rolling rate the ORF1ab and N-gene target failure per total number of strong positive test results.

Figure 2 and supporting information video map. Locations displayed on the Map resulted from subject postal district and date tested. Cases displayed on the Map were accumulated over the assessed period in chronological order generating a heat map. Data were limited to numbers (counts) of cases from Alderley Park data set, and not normalised by the total number of positive test results. Heat map: indicative density of cases of S-gene target failure in the areas highlighted by colours (see colour bar). Map coverage: 98% of cases listed in Table 3 under column “cases of S-gene target failure” were matched with locations in the assessed time range. Accuracy: 95% of matched locations where plotted with high confidence. As a result of map coverage and accuracy, ∼93% of total cases in Table 3 were linked to their locations and indicated on the heat map.

Table 1. Geographical origins of new cases of S-gene target failure, identified at Alderley Park Lighthouse Labs from 1^st – 21^st December 2020, were shown as fractions of total cases of S-gene target failure in the same time range. For comparison, a longer assessment period, 1^st - 30^th December, was shown.